Deep Brain Stimulation Boosts Insulin Sensitivity

One patient with diabetes was able to reduce his medication use while receiving targeted electrical pulses.

Written byShawna Williams
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

X-ray showing DBS electrodes in skullWIKIMEDIA, CRAIG HACKING AND A. PROF FRANK GAILLARDElectrical stimulation of the brain’s ventral striatum increases the body’s sensitivity to insulin, apparently by boosting dopamine levels, researchers reported yesterday (May 23) in Science Translational Medicine.

As Science reports, the finding began serendipitously, when a Dutch man being treated for obsessive-compulsive disorder with deep brain stimulation (DBS) found that his diabetes symptoms also improved. A team of researchers, most of them based at the Academic Medical Center in the Netherlands, recruited him and 14 other patients already using DBS in the same brain region via surgically implanted electrodes. The investigators discovered that the participants’ insulin sensitivity was higher when their brain-zapping devices had been on for 17 hours than when they had been off for the same period of time.

Previous studies had hinted that dopamine levels in the ventral striatum play a role in insulin sensitivity, and that DBS increases those levels. To find out whether the dopamine changes might ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies